Tirzepatide represents a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://polaris-peptide.com/product/tirzepatide-30mg/